國立虎尾科技大學 |

Cannabinoids and Neuropsychiatric Disorders

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Cannabinoids and Neuropsychiatric Disorders/ edited by Eric Murillo-Rodriguez, S. R. Pandi-Perumal, Jaime M. Monti.
other author:	Murillo-Rodriguez, Eric.
Description:	XVII, 153 p. 43 illus., 4 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Molecular biology. -
Online resource:	https://doi.org/10.1007/978-3-030-57369-0
ISBN:	9783030573690

Cannabinoids and Neuropsychiatric Disorders
Cannabinoids and Neuropsychiatric Disorders[electronic resource] /edited by Eric Murillo-Rodriguez, S. R. Pandi-Perumal, Jaime M. Monti. - 1st ed. 2021. - XVII, 153 p. 43 illus., 4 illus. in color.online resource. - Advances in Experimental Medicine and Biology,12642214-8019 ;. - Advances in Experimental Medicine and Biology,889.

This volume highlights the recent advances in the understanding of the endocannabinoid system and the likely benefit from the therapeutic effects of cannabinoid treatment in a variety of health issues. Archeological evidence has shown that Cannabis has a long history of use for multiple purposes, including the treatment of medical conditions. The primary active constituent of the hemp plant Cannabis sativa, delta 9-tetrahydrocannabinol (Δ9-THC), causes euphoria, enhancement of sensory perception, tachycardia, antinociception, difficulties in concentration and impairment of memory, among other effects. Despite these undesirable effects, signaling is mostly inhibitory and suggests a putative role for cannabinoids as therapeutic agents by managing several diseases where inhibition of neurotransmitter release would be beneficial. The themes of this book have been edited and written by world-leaders in the field, The contents of the volume aims at readers from a range of academic and professional disciplines, such as biomedicine, several areas of biology, neurology, clinical medicine and pharmacy.

ISBN: 9783030573690

Standard No.: 10.1007/978-3-030-57369-0doiSubjects--Topical Terms:

583443
Molecular biology.

LC Class. No.: QH506

Dewey Class. No.: 611.01816

Cannabinoids and Neuropsychiatric Disorders
LDR:02610nam a22004095i 4500 001 1051683
003 DE-He213
005 20210921182419.0
007 cr nn 008mamaa
008 220103s2021 sz | s |||| 0|eng d
020 $a 9783030573690 $9 978-3-030-57369-0
024 7 $a 10.1007/978-3-030-57369-0 $2 doi
035 $a 978-3-030-57369-0
050 4 $a QH506
072 7 $a MBGR $2 bicssc
072 7 $a SCI049000 $2 bisacsh
072 7 $a MBGR $2 thema
072 7 $a PSD $2 thema
082 0 4 $a 611.01816 $2 23
245 1 0 $a Cannabinoids and Neuropsychiatric Disorders $h [electronic resource] / $c edited by Eric Murillo-Rodriguez, S. R. Pandi-Perumal, Jaime M. Monti.
250 $a 1st ed. 2021.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a XVII, 153 p. 43 illus., 4 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Advances in Experimental Medicine and Biology, $x 2214-8019 ; $v 1264
520 $a This volume highlights the recent advances in the understanding of the endocannabinoid system and the likely benefit from the therapeutic effects of cannabinoid treatment in a variety of health issues. Archeological evidence has shown that Cannabis has a long history of use for multiple purposes, including the treatment of medical conditions. The primary active constituent of the hemp plant Cannabis sativa, delta 9-tetrahydrocannabinol (Δ9-THC), causes euphoria, enhancement of sensory perception, tachycardia, antinociception, difficulties in concentration and impairment of memory, among other effects. Despite these undesirable effects, signaling is mostly inhibitory and suggests a putative role for cannabinoids as therapeutic agents by managing several diseases where inhibition of neurotransmitter release would be beneficial. The themes of this book have been edited and written by world-leaders in the field, The contents of the volume aims at readers from a range of academic and professional disciplines, such as biomedicine, several areas of biology, neurology, clinical medicine and pharmacy.
650 0 $a Molecular biology. $3 583443
650 0 $a Neurosciences. $3 593561
650 1 4 $a Molecular Medicine. $3 668353
700 1 $a Murillo-Rodriguez, Eric. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1356210
700 1 $a Pandi-Perumal, S. R. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 679174
700 1 $a Monti, Jaime M. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 777970
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030573683
776 0 8 $i Printed edition: $z 9783030573706
776 0 8 $i Printed edition: $z 9783030573713
830 0 $a Advances in Experimental Medicine and Biology, $x 0065-2598 ; $v 889 $3 1253792
856 4 0 $u https://doi.org/10.1007/978-3-030-57369-0
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)